Literature DB >> 13217569

Wegener's granulomatosis: pathology and review of the literature.

G C GODMAN, J CHURG.   

Abstract

Entities:  

Keywords:  GRANULOMA; RESPIRATORY TRACT/diseases

Mesh：

Year:  1954        PMID： 13217569

Source DB:  PubMed          Journal:  AMA Arch Pathol        ISSN： 0096-6711


× No keyword cloud information.
  123 in total

1.  Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis.

Authors:  C E Balding; A J Howie; A B Drake-Lee; C O Savage
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 2.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Churg-Strauss syndrome.

Authors:  M Conron; H L Beynon
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

4.  TWO UNUSUAL CASES OF GIANT CELL MYOCARDITIS ASSOCIATED WITH MITRAL STENOSIS AND WITH WEGENER'S SYNDROME.

Authors:  P C MCCREA; R W CHILDERS
Journal:  Br Heart J       Date:  1964-07

5.  THE MANAGEMENT OF MALIGNANT GRANULOMA.

Authors:  A P ARDOUIN
Journal:  Proc R Soc Med       Date:  1964-04

6.  ORBITAL GRANULOMATA ASSOCIATED WITH WIDESPREAD ANGIITIS.

Authors:  R B HARCOURT
Journal:  Br J Ophthalmol       Date:  1964-12       Impact factor: 4.638

7.  Prognostic factors in Wegener's granulomatosis.

Authors:  L Briedigkeit; R Kettritz; U Göbel; R Natusch
Journal:  Postgrad Med J       Date:  1993-11       Impact factor: 2.401

Review 8.  Wegener's granulomatosis in childhood. Review of the literature and case report.

Authors:  G Neumann; G Benz-Bohm; M Rister
Journal:  Pediatr Radiol       Date:  1984

9.  Granulomatous glomerulonephritis in Wegener's granulomatosis.

Authors:  Y Yoshikawa; T Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

10.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.